Nexalin Technology, Inc. Common Stock · Healthcare · Medical Equipment
As of 2026-06-26, Nexalin Technology, Inc. Common Stock (NXL) has a 3-month relative strength percentile of 31 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 36. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 11.5%, relative volume 1.33×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
31 is not yet a leadership-grade RS read, Market Stance is 47
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Daily range, ATR, beta, and the math for a 1-ADR stop.
NXL is in a stage 4 downtrend, week 2. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: -14.9% / -50.0%.
No attention data for this ticker yet — it joins the daily scan once a baseline builds.
NXL appears in 1 ETF as of Mar 2026: VXF at 0.00% weight, $44K notional.
Top 1 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value |
|---|---|---|
| VXFVanguard Extended Market ETF | 0.00% | $44K |
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NXL Jan avg: 8.98% median: 3.97% win: 75% σ: 23.27% n: 4 2022-09-19 → 2026-05-29 | NXL Feb avg: -13.03% median: -13.70% win: 0% σ: 4.71% n: 4 2022-09-19 → 2026-05-29 | NXL Mar avg: 71.82% median: -18.00% win: 25% σ: 186.50% n: 4 2022-09-19 → 2026-05-29 | NXL Apr avg: 1.78% median: 2.25% win: 75% σ: 6.54% n: 4 2022-09-19 → 2026-05-29 | NXL May avg: -3.07% median: -14.86% win: 50% σ: 55.58% n: 4 2022-09-19 → 2026-05-29 | NXL Jun avg: 42.78% median: 3.91% win: 67% σ: 86.07% n: 3 2022-09-19 → 2026-05-29 (current) | NXL Jul avg: -13.36% median: -9.35% win: 33% σ: 16.95% n: 3 2022-09-19 → 2026-05-29 | NXL Aug avg: -23.09% median: -19.90% win: 0% σ: 20.50% n: 3 2022-09-19 → 2026-05-29 | NXL Sep avg: -21.18% median: -15.74% win: 0% σ: 23.65% n: 4 2022-09-19 → 2026-05-29 | NXL Oct avg: 84.46% median: 49.83% win: 75% σ: 131.77% n: 4 2022-09-19 → 2026-05-29 | NXL Nov avg: 33.39% median: 46.85% win: 75% σ: 43.30% n: 4 2022-09-19 → 2026-05-29 | NXL Dec avg: -36.63% median: -41.15% win: 25% σ: 30.33% n: 4 2022-09-19 → 2026-05-29 |